BiotechTube
Home/BinDeBio/Sui Changjiang
SC

Sui Changjiang

Head, Shenyang BinDeBio

BinDeBio

Therapeutic Areas

OncologyImmunology

BinDeBio Pipeline

DrugIndicationPhase
CD19 CAR-TB-cell LymphomaClinical

Leadership Team at BinDeBio

LJ
Li Jing
President, Shenzhen BinDeBio
View full BinDeBio profile